Mylan launches generic Carboplatin Injection in multi-dose vials

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Mylan Inc. launched Carboplatin Injection, 50 mg/5 ml, in multi-dose vials—the generic version of Bristol-Myers Squibb’s Paraplatin Injection.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Login